Results 241 to 250 of about 571,071 (309)

Ampulla of Vater Metastasis From Colon Cancer Presenting As Obstructive Jaundice. [PDF]

Cureus
Gupta P, Senthamizhselvan K, Mohan P, Ramkumar G, Rajesh NG.   +4 more
europepmc   +1 more source

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

Molecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim, Alvin Kunyao Guo, Yoko Itahana, Srinivasaraghavan Kannan, Valerie Goh, Mingmin Ong, Terina Yan Wen Tay, Weiying Ye, Sabhashina Radha Krishnan, Jun Nishiyama, Chandra S Verma, Koji Itahana   +11 more
wiley   +1 more source

From Control to Clue: Integrating Olfaction into the Object-Choice Task for Domestic Dogs (<i>Canis familiaris</i>). [PDF]

Animals (Basel)
Bergquist S, Horowitz A.
europepmc   +1 more source

Point-by-Point Response - Review I

, 2019
openaire   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba, Mark Shacker, Timothy P. Fleming, Michael A. Smith, Ross M. Bremner, Narendra V. Sankpal   +5 more
wiley   +1 more source

Gene Model for the ortholog of <i>Ilp2</i> in <i>Drosophila ananassae</i>. [PDF]

MicroPubl Biol
Myers AR, Huber R, Arsham AM, Rele CP, Reed L.   +4 more
europepmc   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

Molecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès   +12 more
wiley   +1 more source

Integrated Dynamic Modeling and Ground Test Validation for Spacecraft Micro-Vibration Suppression Considering Disturbance, Isolation, and Pointing Control. [PDF]

Sensors (Basel)
Wang H, Yan H, Tian L, Zang X, Zu Y.
europepmc   +1 more source